The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insomnia Pharmacological Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Insomnia Pharmacological Treatment market size is expected to reach US$ 3710.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Pharmacological Treatment in various end use industries. The expanding demands from the Homecare, Clinic and Hospital,, are propelling Insomnia Pharmacological Treatment market. Prescription Sleep Aids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Over-the-Counter Sleep Aids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Pharmacological Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Pharmacological Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Pharmacological Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Pharmacological Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Pharmacological Treatment covered in this report include Eisai, Co. Ltd. (Japan), Merck & Co., Inc (US), Meda Consumer Healthcare Inc (US), Pfizer, Inc (US), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (US) and Purdue Pharma L.P (US), etc.
The global Insomnia Pharmacological Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)
Global Insomnia Pharmacological Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Pharmacological Treatment market, Segment by Type:
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Global Insomnia Pharmacological Treatment market, by Application
Homecare
Clinic
Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia Pharmacological Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Insomnia Pharmacological Treatment market size is expected to reach US$ 3710.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Pharmacological Treatment in various end use industries. The expanding demands from the Homecare, Clinic and Hospital,, are propelling Insomnia Pharmacological Treatment market. Prescription Sleep Aids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Over-the-Counter Sleep Aids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Pharmacological Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Pharmacological Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Pharmacological Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Pharmacological Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Pharmacological Treatment covered in this report include Eisai, Co. Ltd. (Japan), Merck & Co., Inc (US), Meda Consumer Healthcare Inc (US), Pfizer, Inc (US), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (US) and Purdue Pharma L.P (US), etc.
The global Insomnia Pharmacological Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)
Global Insomnia Pharmacological Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Pharmacological Treatment market, Segment by Type:
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Global Insomnia Pharmacological Treatment market, by Application
Homecare
Clinic
Hospital
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia Pharmacological Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Insomnia Pharmacological Treatment
1.1 Insomnia Pharmacological Treatment Market Overview
1.1.1 Insomnia Pharmacological Treatment Product Scope
1.1.2 Insomnia Pharmacological Treatment Market Status and Outlook
1.2 Global Insomnia Pharmacological Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Insomnia Pharmacological Treatment Market Size by Region (2018-2029)
1.4 Global Insomnia Pharmacological Treatment Historic Market Size by Region (2018-2023)
1.5 Global Insomnia Pharmacological Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Insomnia Pharmacological Treatment Market Size (2018-2029)
1.6.1 North America Insomnia Pharmacological Treatment Market Size (2018-2029)
1.6.2 Europe Insomnia Pharmacological Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size (2018-2029)
1.6.4 Latin America Insomnia Pharmacological Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Insomnia Pharmacological Treatment Market Size (2018-2029)
2 Insomnia Pharmacological Treatment Market by Type
2.1 Introduction
2.1.1 Prescription Sleep Aids
2.1.2 Over-the-Counter Sleep Aids
2.2 Global Insomnia Pharmacological Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Insomnia Pharmacological Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Insomnia Pharmacological Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Insomnia Pharmacological Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Insomnia Pharmacological Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Insomnia Pharmacological Treatment Revenue Breakdown by Type (2018-2029)
3 Insomnia Pharmacological Treatment Market Overview by Application
3.1 Introduction
3.1.1 Homecare
3.1.2 Clinic
3.1.3 Hospital
3.2 Global Insomnia Pharmacological Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Insomnia Pharmacological Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Insomnia Pharmacological Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Insomnia Pharmacological Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Insomnia Pharmacological Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Insomnia Pharmacological Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Insomnia Pharmacological Treatment Revenue Breakdown by Application (2018-2029)
4 Insomnia Pharmacological Treatment Competition Analysis by Players
4.1 Global Insomnia Pharmacological Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Pharmacological Treatment as of 2022)
4.3 Date of Key Players Enter into Insomnia Pharmacological Treatment Market
4.4 Global Top Players Insomnia Pharmacological Treatment Headquarters and Area Served
4.5 Key Players Insomnia Pharmacological Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Insomnia Pharmacological Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eisai, Co. Ltd. (Japan)
5.1.1 Eisai, Co. Ltd. (Japan) Profile
5.1.2 Eisai, Co. Ltd. (Japan) Main Business
5.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Products, Services and Solutions
5.1.4 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Eisai, Co. Ltd. (Japan) Recent Developments
5.2 Merck & Co., Inc (US)
5.2.1 Merck & Co., Inc (US) Profile
5.2.2 Merck & Co., Inc (US) Main Business
5.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Products, Services and Solutions
5.2.4 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Merck & Co., Inc (US) Recent Developments
5.3 Meda Consumer Healthcare Inc (US)
5.3.1 Meda Consumer Healthcare Inc (US) Profile
5.3.2 Meda Consumer Healthcare Inc (US) Main Business
5.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Products, Services and Solutions
5.3.4 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer, Inc (US) Recent Developments
5.4 Pfizer, Inc (US)
5.4.1 Pfizer, Inc (US) Profile
5.4.2 Pfizer, Inc (US) Main Business
5.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Products, Services and Solutions
5.4.4 Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer, Inc (US) Recent Developments
5.5 Sanofi (France)
5.5.1 Sanofi (France) Profile
5.5.2 Sanofi (France) Main Business
5.5.3 Sanofi (France) Insomnia Pharmacological Treatment Products, Services and Solutions
5.5.4 Sanofi (France) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi (France) Recent Developments
5.6 Takeda Pharmaceutical Company Ltd. (Japan)
5.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Profile
5.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Main Business
5.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Products, Services and Solutions
5.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Developments
5.7 Pernix Therapeutics (US)
5.7.1 Pernix Therapeutics (US) Profile
5.7.2 Pernix Therapeutics (US) Main Business
5.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Products, Services and Solutions
5.7.4 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Pernix Therapeutics (US) Recent Developments
5.8 Purdue Pharma L.P (US)
5.8.1 Purdue Pharma L.P (US) Profile
5.8.2 Purdue Pharma L.P (US) Main Business
5.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Products, Services and Solutions
5.8.4 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Purdue Pharma L.P (US) Recent Developments
6 North America
6.1 North America Insomnia Pharmacological Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Insomnia Pharmacological Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Insomnia Pharmacological Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Insomnia Pharmacological Treatment Market Dynamics
11.1 Insomnia Pharmacological Treatment Industry Trends
11.2 Insomnia Pharmacological Treatment Market Drivers
11.3 Insomnia Pharmacological Treatment Market Challenges
11.4 Insomnia Pharmacological Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
